What is Hyster-Yale's operating income?

Hyster-Yale's total operating income in 2025 was -$22.10 million, based on the following breakdown: Total Gross Profit: $632.80 million Total Operating Expenses: $696.40 million

Hyster-Yale (HY) Financials

$32.86 +0.19 (+0.57%)

As of 09:58 AM Eastern

Compare

Annual Income Statements for Hyster-Yale

This table shows Hyster-Yale's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	75	43	49	35	36	37	-173	-74	126	142	-60
Consolidated Net Income / (Loss)	75	42	49	34	37	39	-183	-72	128	144	-58
Net Income / (Loss) Continuing Operations	75	42	49	34	37	39	-183	-72	128	131	-100
Total Pre-Tax Income	105	38	94	37	48	42	-155	-62	181	219	-43
Total Operating Income	104	33	74	39	54	50	-152	-39	209	245	-22
Total Gross Profit	431	428	503	497	542	465	363	434	786	896	633
Total Revenue	2,578	2,570	2,885	3,179	3,292	2,812	3,076	3,548	4,118	4,308	3,769
Operating Revenue	2,578	2,570	2,885	3,179	3,292	2,812	3,076	3,548	4,118	4,308	3,769
Total Cost of Revenue	2,147	2,142	2,383	2,682	2,750	2,347	2,712	3,114	3,333	3,413	3,137
Operating Cost of Revenue	2,147	2,142	2,383	2,682	2,750	2,347	2,712	3,114	3,333	3,413	3,137
Total Operating Expenses	327	395	429	458	488	416	516	473	577	664	696
Selling, General & Admin Expense	327	395	429	458	488	416	450	473	577	628	617
Impairment Charge	-	-	-	-	-	0.00	66	0.00	0.00	0.00	6.80
Restructuring Charge	-	-	-	-	-	-	-	0.00	0.00	36	73
Total Other Income / (Expense), net	1.00	5.40	20	-2.20	-6.00	-7.70	-2.60	-23	-28	-26	-21
Interest Expense	4.70	6.70	15	16	20	14	16	28	37	34	31
Interest & Investment Income	6.10	7.10	28	10	9.30	6.60	12	11	9.80	5.50	10
Other Income / (Expense), net	-0.40	5.00	6.30	3.80	4.50	-0.60	1.20	-5.90	-0.20	2.50	0.00
Income Tax Expense	29	-4.00	45	2.30	11	3.70	28	9.20	53	75	15
Net Income / (Loss) Attributable to Noncontrolling Interest	0.40	-0.50	0.30	-0.40	0.80	1.40	-10	2.50	2.20	1.90	2.10
Basic Earnings per Share	$4.58	$2.61	$2.95	$2.10	$2.15	$2.21	($10.29)	($4.38)	$7.35	$8.16	($3.40)
Weighted Average Basic Shares Outstanding	16.31M	16.38M	16.45M	16.54M	16.67M	16.81M	16.84M	17.16M	17.49M	17.70M	17.90M
Diluted Earnings per Share	$4.57	$2.61	$2.94	$2.09	$2.14	$2.21	($10.29)	($4.38)	$7.24	$8.04	($3.40)
Weighted Average Diluted Shares Outstanding	16.31M	16.38M	16.45M	16.54M	16.67M	16.81M	16.84M	17.16M	17.49M	17.70M	17.90M
Weighted Average Basic & Diluted Shares Outstanding	16.31M	16.38M	16.45M	16.54M	16.67M	16.81M	16.84M	17.16M	17.49M	17.70M	17.90M
Cash Dividends to Common per Share	$1.13	$1.17	$1.20	$1.23	$1.26	$1.27	$1.29	$1.29	$1.30	$1.38	$1.43

This table shows Hyster-Yale's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	36	25	52	63	17	10	8.60	-14	-2.30	-53	-31
Consolidated Net Income / (Loss)	36	26	52	64	18	11	8.70	-13	-1.70	-52	-30
Net Income / (Loss) Continuing Operations	36	26	52	64	18	27	8.70	-13	-2.70	-93	-41
Total Pre-Tax Income	53	42	77	90	28	24	17	-13	-4.60	-42	-32
Total Operating Income	59	49	84	96	33	32	21	-8.50	2.30	-37	-28
Total Gross Profit	204	210	236	259	193	208	178	168	156	131	125
Total Revenue	1,001	1,027	1,057	1,168	1,016	1,068	910	957	979	923	795
Operating Revenue	1,001	1,027	1,057	1,168	1,016	1,068	910	957	979	923	795
Total Cost of Revenue	798	818	821	909	823	860	733	788	823	792	670
Operating Cost of Revenue	798	818	821	909	823	860	733	788	823	792	670
Total Operating Expenses	145	161	152	164	160	160	157	177	155	209	164
Selling, General & Admin Expense	145	161	152	164	159	153	156	161	153	147	151
Restructuring Charge	-	-	0.00	0.00	1.20	-	0.40	16	2.00	56	13
Total Other Income / (Expense), net	-6.00	-7.00	-6.90	-5.60	-5.00	-8.30	-4.50	-4.70	-6.90	-4.70	-4.10
Interest Expense	9.60	9.10	8.90	8.80	8.40	7.70	7.70	7.90	8.00	7.60	7.20
Interest & Investment Income	2.90	2.00	1.00	2.10	3.60	-1.20	2.90	2.70	1.60	3.20	3.30
Other Income / (Expense), net	0.70	0.10	1.00	1.10	-0.20	0.60	0.30	0.50	-0.50	-0.30	-0.20
Income Tax Expense	16	16	25	26	10	13	8.10	0.20	-2.90	9.70	-1.80
Net Income / (Loss) Attributable to Noncontrolling Interest	0.60	0.50	0.30	0.60	0.60	0.40	0.10	0.50	0.60	0.90	0.20
Basic Earnings per Share	$2.08	$1.48	$2.97	$3.62	$0.98	$0.59	$0.49	($0.79)	($0.13)	($2.97)	($1.71)
Weighted Average Basic Shares Outstanding	17.18M	17.49M	17.34M	17.49M	17.50M	17.70M	17.56M	17.71M	17.72M	17.90M	17.82M
Diluted Earnings per Share	$2.06	$1.42	$2.93	$3.58	$0.97	$0.56	$0.48	($0.79)	($0.13)	($2.96)	($1.71)
Weighted Average Diluted Shares Outstanding	17.41M	17.49M	17.59M	17.66M	17.75M	17.70M	17.77M	17.71M	17.72M	17.90M	17.82M
Weighted Average Basic & Diluted Shares Outstanding	17.19M	17.49M	17.50M	17.50M	17.51M	17.70M	17.71M	17.72M	17.73M	17.90M	17.92M
Cash Dividends to Common per Share	$0.33	-	$0.33	$0.35	$0.35	-	$0.35	$0.36	$0.36	-	$0.36

This table details how cash moves in and out of Hyster-Yale's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	44	-112	177	-136	-19	87	-86	-6.50	20	73	41
Net Cash From Operating Activities	89	-49	165	68	77	167	-254	41	151	171	86
Net Cash From Continuing Operating Activities	89	-49	165	68	77	167	-254	41	151	193	86
Net Income / (Loss) Continuing Operations	75	42	49	34	37	39	-183	-72	128	144	-58
Consolidated Net Income / (Loss)	75	42	49	34	37	39	-183	-72	128	144	-58
Depreciation Expense	29	39	43	44	43	43	46	43	45	48	46
Amortization Expense	1.20	1.10	1.40	1.70	1.90	1.70	3.10	1.40	1.40	1.50	1.40
Non-Cash Adjustments To Reconcile Net Income	6.40	-5.40	2.90	36	34	29	43	48	61	92	65
Changes in Operating Assets and Liabilities, net	-22	-126	69	-49	-39	55	-162	19	-84	-92	32
Net Cash From Investing Activities	-31	-145	-47	-111	-42	-44	-25	-35	-35	-48	-63
Net Cash From Continuing Investing Activities	-31	-145	-47	-111	-42	-44	-25	-35	-35	-43	-58
Purchase of Property, Plant & Equipment	-47	-43	-41	-39	-50	-52	-44	-29	-35	-48	-63
Acquisitions	-	-116	-1.00	-78	-	0.00	0.00	0.00	0.00	2.20	2.60
Purchase of Investments	0.00	0.00	-6.60	-	-	-	0.00	-8.40	-3.20	0.00	0.00
Sale of Property, Plant & Equipment	14	14	1.30	5.90	7.70	8.00	4.10	1.30	1.90	1.80	2.40
Divestitures	0.90	-	-	-	-	-	0.00	0.00	1.10	0.60	0.00
Sale and/or Maturity of Investments	-	-	-	-	0.00	0.00	16	0.50	1.10	0.00	0.00
Net Cash From Financing Activities	-7.10	78	53	-88	-52	-41	194	-11	-101	-100	-0.80
Net Cash From Continuing Financing Activities	-7.10	78	53	-88	-52	-41	194	-11	-101	-72	8.20
Repayment of Debt	-35	-58	-192	-145	-98	-84	-70	-98	-162	-199	-173
Repurchase of Common Equity	-	-	-	-	-	-	-	0.00	0.00	14	4.50
Payment of Dividends	-18	-19	-20	-21	-21	-22	-22	-22	-24	-25	-27
Issuance of Debt	46	156	266	78	68	65	285	109	85	138	204
Other Net Changes in Cash	-	-	-	-	-	4.20	-1.50	-0.80	4.10	-5.20	4.00

This table details how cash moves in and out of Hyster-Yale's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	13	0.60	-17	4.30	9.10	59	-19	-10	4.20	66	-41
Net Cash From Operating Activities	60	46	22	-2.50	70	81	-36	29	37	57	-33
Net Cash From Continuing Operating Activities	60	46	22	-2.50	70	81	-36	29	37	57	-33
Net Income / (Loss) Continuing Operations	36	26	52	64	18	11	8.70	-13	-1.70	-52	-30
Consolidated Net Income / (Loss)	36	26	52	64	18	11	8.70	-13	-1.70	-52	-30
Depreciation Expense	11	11	12	12	12	12	11	12	11	12	11
Amortization Expense	0.30	0.40	0.40	0.30	0.50	0.30	0.40	0.40	0.30	0.30	0.30
Non-Cash Adjustments To Reconcile Net Income	11	21	18	13	20	19	16	23	0.60	26	0.80
Changes in Operating Assets and Liabilities, net	1.70	-13	-59	-92	20	39	-72	7.50	27	70	-15
Net Cash From Investing Activities	-7.90	-15	-7.00	-12	-12	-17	-10	-15	-14	-23	-9.30
Net Cash From Continuing Investing Activities	-7.90	-18	-7.00	-12	-12	-13	-10	-15	-14	-18	-9.30
Purchase of Property, Plant & Equipment	-8.30	-17	-7.50	-12	-10	-18	-11	-14	-15	-24	-9.80
Sale of Property, Plant & Equipment	0.40	0.70	0.50	0.50	0.40	0.40	0.30	1.10	0.30	0.70	0.50
Net Cash From Financing Activities	-40	-31	-31	19	-51	-38	26	-26	-18	18	1.30
Net Cash From Continuing Financing Activities	-40	-28	-31	19	-51	-9.90	26	-26	-18	27	1.30
Repayment of Debt	-41	-41	-50	-54	-53	-73	-43	-41	-42	-48	-37
Repurchase of Common Equity	-	0.10	-9.10	-	-	23	-4.50	0.10	-0.10	9.00	-0.70
Payment of Dividends	-5.60	-5.60	-5.70	-7.40	-6.10	-6.10	-6.20	-7.70	-6.30	-6.50	-6.40
Issuance of Debt	6.50	15	34	81	8.40	46	79	22	31	72	45
Other Net Changes in Cash	0.30	1.10	-1.50	-0.60	1.80	-	1.40	2.30	-0.60	0.90	-0.50

This table presents Hyster-Yale's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	1,096	1,287	1,648	1,742	1,847	1,860	545	2,026	2,079	2,029	2,021
Total Current Assets	819	810	1,131	1,132	1,156	1,130	0.00	1,459	1,490	1,433	1,347
Cash & Equivalents	155	43	220	84	65	151	-	59	79	97	123
Accounts Receivable	324	375	453	466	468	412	-	524	498	488	490
Inventories, net	305	352	412	534	560	509	-	800	816	754	634
Prepaid Expenses	35	39	46	49	63	57	-	77	98	94	100
Plant, Property, & Equipment, net	185	255	265	296	309	340	331	310	314	307	329
Total Noncurrent Assets	93	222	251	314	383	498	214	258	275	289	345
Long-Term Investments	43	46	82	76	80	80	-	59	57	56	58
Goodwill	0.00	51	59	108	107	115	57	51	53	55	56
Intangible Assets	3.60	56	56	68	60	59	51	43	39	33	32
Noncurrent Deferred & Refundable Income Taxes	33	44	17	26	31	24	-	2.60	3.00	6.70	6.80
Other Noncurrent Operating Assets	13	25	37	36	105	183	107	102	123	139	192
Total Liabilities & Shareholders' Equity	1,096	1,287	1,648	1,742	1,847	1,860	1,970	2,026	2,079	2,029	2,021
Total Liabilities	633	817	1,076	1,183	1,270	1,208	1,587	1,801	1,672	1,535	1,528
Total Current Liabilities	505	577	692	776	817	756	0.00	1,343	1,219	1,058	1,002
Short-Term Debt	34	129	75	91	82	83	-	286	253	199	242
Accounts Payable	295	259	404	437	417	428	-	586	524	448	396
Current Deferred Revenue	-	-	-	38	49	42	-	140	78	57	47
Current Employee Benefit Liabilities	48	44	52	56	66	46	-	64	87	106	101
Other Current Liabilities	-	-	-	-	-	182	-	245	270	241	211
Total Noncurrent Liabilities	128	240	383	406	453	738	443	725	695	719	526
Long-Term Debt	20	82	216	210	205	412	262	534	483	484	252
Asset Retirement Reserve & Litigation Obligation	18	20	34	25	31	30	-	34	51	38	43
Noncurrent Deferred & Payable Income Tax Liabilities	0.00	11	13	18	15	15	13	13	13	8.40	8.20
Other Noncurrent Operating Liabilities	69	90	109	130	188	260	169	138	149	189	224
Redeemable Noncontrolling Interest	-	-	-	-	-	-	0.00	14	15	15	16
Total Equity & Noncontrolling Interests	463	470	572	560	577	651	383	211	392	479	476
Total Preferred & Common Equity	461	464	566	527	544	617	357	204	390	475	472
Total Common Equity	461	464	565	527	544	617	46	204	390	475	472
Common Stock	320	320	324	322	322	313	-	298	328	351	355
Retained Earnings	337	360	389	407	427	443	249	153	256	375	289
Treasury Stock	-43	-37	-32	-24	-16	-6.00	-	-	0.00	-14	-14
Accumulated Other Comprehensive Income / (Loss)	-154	-179	-116	-178	-189	-133	-202	-246	-194	-237	-158
Noncontrolling Interest	1.90	6.60	6.90	32	33	34	26	6.50	2.10	4.10	4.30

This table presents Hyster-Yale's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	1,933	2,110	2,053	2,118	2,116	2,172	2,055	2,075	2,061	1,958
Total Current Assets	1,376	1,552	1,501	1,526	1,529	1,559	1,455	1,457	1,444	1,305
Cash & Equivalents	69	66	78	62	67	76	77	67	71	82
Accounts Receivable	460	582	512	521	579	543	506	512	521	471
Inventories, net	779	820	815	842	791	855	773	777	740	644
Prepaid Expenses	68	84	95	101	93	86	99	101	112	108
Plant, Property, & Equipment, net	302	300	299	312	311	317	313	316	321	328
Total Noncurrent Assets	255	258	254	281	276	296	287	302	296	326
Long-Term Investments	56	52	54	52	53	60	52	56	57	52
Goodwill	49	52	51	52	52	58	51	55	56	55
Intangible Assets	43	41	40	37	36	36	33	34	33	31
Noncurrent Deferred & Refundable Income Taxes	4.80	2.90	2.60	3.00	2.70	2.80	6.90	7.90	8.00	7.30
Other Noncurrent Operating Assets	103	109	106	136	133	139	144	149	143	181
Total Liabilities & Shareholders' Equity	1,933	2,110	2,053	2,118	2,116	2,172	2,055	2,075	2,061	1,958
Total Liabilities	1,798	1,804	1,733	1,689	1,634	1,623	1,526	1,512	1,505	1,507
Total Current Liabilities	1,307	1,371	1,299	1,221	1,172	1,149	1,054	1,042	1,037	993
Short-Term Debt	272	290	267	235	253	221	241	228	216	254
Accounts Payable	553	577	540	566	507	528	464	465	472	400
Current Deferred Revenue	153	120	99	71	66	64	52	48	44	50
Current Employee Benefit Liabilities	51	59	70	52	67	83	65	78	87	65
Other Current Liabilities	278	309	313	290	272	247	221	214	214	215
Total Noncurrent Liabilities	490	432	433	468	462	475	472	470	468	514
Long-Term Debt	273	252	243	240	249	247	243	245	252	251
Asset Retirement Reserve & Litigation Obligation	32	35	42	46	36	38	41	37	38	44
Noncurrent Deferred & Payable Income Tax Liabilities	11	12	12	12	12	12	9.80	10	9.20	8.10
Other Noncurrent Operating Liabilities	167	127	131	166	161	172	179	177	168	211
Redeemable Noncontrolling Interest	14	14	14	15	14	0.00	15	15	15	17
Total Equity & Noncontrolling Interests	122	292	306	414	468	534	514	549	540	434
Total Preferred & Common Equity	114	291	304	412	466	530	510	545	536	430
Total Common Equity	114	291	304	412	466	530	510	545	536	430
Common Stock	295	310	313	337	345	350	353	355	357	348
Retained Earnings	151	207	237	302	359	370	377	357	348	252
Treasury Stock	0.00	-0.10	0.00	-9.10	-9.10	-8.70	-17	-16	-15	-3.90
Accumulated Other Comprehensive Income / (Loss)	-332	-225	-245	-218	-230	-181	-204	-151	-153	-166
Noncontrolling Interest	7.50	1.80	1.80	2.30	2.20	4.10	4.30	4.20	4.30	4.30

This table displays calculated financial ratios and metrics derived from Hyster-Yale's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
DEI Shares Outstanding	16,323,816.00	16,390,754.00	16,462,320.00	16,560,722.00	16,666,917.00	16,805,437.00	16,826,900.00	-	-	-	17,733,794.00
DEI Adjusted Shares Outstanding	16,323,816.00	16,390,754.00	16,462,320.00	16,560,722.00	16,666,917.00	16,805,437.00	16,826,900.00	-	-	-	17,733,794.00
DEI Earnings Per Adjusted Shares Outstanding	4.58	2.61	2.95	2.10	2.15	2.21	-10.28	-	-	-	-3.39
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	74	36	39	36	41	46	-107	-27	148	161	-15
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-2.66%	13.10%	17.52%	-1.59%
Earnings before Interest and Taxes (EBIT)	103	38	80	43	58	49	-151	-45	209	247	-22
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	133	78	125	88	104	94	-102	-0.20	255	296	25
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	93	-238	70	-104	23	51	243	-345	57	143	-35
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	318	593	561	702	719	714	364	681	772	790	810
Increase / (Decrease) in Invested Capital	-19	275	-31	141	18	-5.90	-350	318	91	19	20
Book Value per Share	$28.22	$28.28	$34.34	$31.83	$32.66	$36.71	$2.75	$12.07	$22.69	$27.14	$26.62
Tangible Book Value per Share	$28.00	$21.76	$27.34	$21.21	$22.65	$26.40	($3.62)	$6.52	$17.30	$22.13	$21.65
Total Capital	516	682	863	861	864	1,146	645	1,045	1,142	935	987
Total Debt	53	211	291	302	287	495	262	820	735	441	494
Total Long-Term Debt	20	82	216	210	205	412	262	534	483	242	252
Net Debt	-145	122	-11	142	142	264	262	702	600	289	313
Capital Expenditures (CapEx)	32	29	40	33	42	44	40	28	34	46	60
Debt-free, Cash-free Net Working Capital (DFCFNWC)	192	319	293	363	357	306	0.00	343	445	478	464
Debt-free Net Working Capital (DFNWC)	347	363	514	447	421	457	0.00	402	524	574	588
Net Working Capital (NWC)	314	234	439	355	339	374	0.00	116	272	375	345
Net Nonoperating Expense (NNE)	-0.72	-5.96	-10	2.06	4.58	7.02	77	44	20	17	43
Net Nonoperating Obligations (NNO)	-145	122	-11	142	142	62	-19	456	365	296	318
Total Depreciation and Amortization (D&A)	30	40	44	46	45	45	49	45	47	49	47
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.58	$2.61	$2.95	$2.10	$2.15	$2.21	($10.29)	($4.38)	$7.35	$8.16	($3.40)
Adjusted Weighted Average Basic Shares Outstanding	16.33M	16.40M	16.47M	16.57M	16.67M	16.81M	16.84M	17.16M	17.49M	17.70M	17.90M
Adjusted Diluted Earnings per Share	$4.57	$2.61	$2.94	$2.09	$2.14	$2.21	($10.29)	($4.38)	$7.24	$8.04	($3.40)
Adjusted Weighted Average Diluted Shares Outstanding	16.33M	16.40M	16.47M	16.57M	16.67M	16.81M	16.84M	17.16M	17.49M	17.70M	17.90M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	16.33M	16.40M	16.47M	16.57M	16.67M	16.81M	16.84M	17.16M	17.49M	17.70M	17.90M
Normalized Net Operating Profit after Tax (NOPAT)	74	23	39	36	41	46	-61	-27	148	166	40
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Hyster-Yale's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	17,707,665.00	17,720,627.00	17,733,794.00	17,900,088.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	17,707,665.00	17,720,627.00	17,733,794.00	17,900,088.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-0.79	-0.13	-2.96	-1.70
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.18%	11.97%	5.72%	7.11%	1.49%	3.92%	-13.83%	-18.11%	-3.64%	-	-12.65%
EBITDA Growth	543.13%	85.02%	73.66%	61.36%	-36.39%	-25.62%	-65.94%	-96.16%	-70.29%	-	-150.30%
EBIT Growth	317.22%	122.83%	91.42%	72.37%	-44.52%	-32.58%	-74.53%	-108.27%	-94.53%	-	-230.56%
NOPAT Growth	332.66%	888.84%	74.89%	51.14%	-48.30%	-52.02%	-80.46%	-108.77%	-92.32%	-	-277.69%
Net Income Growth	199.45%	970.83%	90.44%	64.69%	-51.10%	-58.37%	-83.20%	-120.97%	-109.55%	-	-448.28%
EPS Growth	193.64%	1,083.33%	89.03%	61.99%	-52.91%	-60.56%	-83.62%	-122.07%	-113.40%	-	-456.25%
Operating Cash Flow Growth	76.83%	623.81%	148.89%	-106.98%	16.25%	76.97%	-262.50%	1,256.00%	-47.08%	-	9.62%
Free Cash Flow Firm Growth	-147.74%	80.71%	-204.97%	91.92%	-42.57%	93.24%	88.29%	-1.28%	93.91%	-	149.84%
Invested Capital Growth	27.35%	13.31%	0.00%	16.68%	25.42%	2.40%	12.26%	5.91%	1.27%	-	-7.02%
Revenue Q/Q Growth	-8.20%	2.60%	2.85%	10.56%	-13.01%	5.06%	-14.72%	5.07%	2.35%	-	-13.86%
EBITDA Q/Q Growth	4.57%	-14.67%	60.17%	12.90%	-58.78%	-0.22%	-26.67%	-87.27%	219.05%	-	34.90%
EBIT Q/Q Growth	5.70%	-17.71%	73.77%	14.03%	-65.98%	0.00%	-34.35%	-137.04%	122.50%	-	24.80%
NOPAT Q/Q Growth	-9.70%	-25.99%	88.07%	20.25%	-69.11%	-31.32%	-23.40%	-153.94%	127.06%	-	24.73%
Net Income Q/Q Growth	-6.19%	-29.40%	101.56%	23.36%	-72.14%	-39.89%	-18.69%	-254.02%	87.31%	-	41.28%
EPS Q/Q Growth	-6.79%	-31.07%	106.34%	22.18%	-72.91%	-42.27%	-14.29%	-264.58%	83.54%	-	42.23%
Operating Cash Flow Q/Q Growth	68.44%	-24.38%	-50.88%	-111.16%	2,904.00%	15.12%	-145.11%	179.40%	28.37%	-	-158.23%
Free Cash Flow Firm Q/Q Growth	84.11%	45.60%	-1,119.81%	92.34%	-180.36%	97.42%	-2,014.11%	33.71%	83.13%	-	193.83%
Invested Capital Q/Q Growth	-5.21%	8.99%	3.21%	9.41%	1.89%	-11.01%	13.16%	3.22%	-2.57%	-	2.62%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	20.34%	20.41%	22.31%	22.20%	18.98%	19.45%	19.52%	17.58%	15.92%	-	15.69%
EBITDA Margin	7.08%	5.89%	9.17%	9.37%	4.44%	4.22%	3.62%	0.44%	1.37%	-	-2.09%
Operating Margin	5.85%	4.74%	7.93%	8.18%	3.26%	3.03%	2.34%	-0.89%	0.23%	-	-3.52%
EBIT Margin	5.92%	4.75%	8.03%	8.28%	3.24%	3.08%	2.37%	-0.84%	0.18%	-	-3.55%
Profit (Net Income) Margin	3.64%	2.50%	4.90%	5.47%	1.75%	1.00%	0.96%	-1.40%	-0.17%	-	-3.81%
Tax Burden Percent	69.20%	61.63%	67.36%	71.00%	63.35%	44.58%	51.79%	101.52%	36.96%	-	94.39%
Interest Burden Percent	88.70%	85.45%	90.68%	93.07%	85.41%	72.95%	77.78%	165.00%	-255.56%	-	113.83%
Effective Tax Rate	30.80%	38.37%	32.64%	29.00%	36.65%	55.42%	48.21%	0.00%	0.00%	-	0.00%
Return on Invested Capital (ROIC)	25.68%	16.56%	56.00%	30.53%	11.03%	7.44%	5.96%	-2.74%	0.72%	-	-10.44%
ROIC Less NNEP Spread (ROIC-NNEP)	24.66%	15.51%	53.47%	29.58%	10.18%	6.32%	5.33%	-4.73%	-0.23%	-	-13.31%
Return on Net Nonoperating Assets (RNNOA)	43.74%	20.16%	45.76%	31.16%	8.84%	4.64%	4.07%	-3.39%	-0.15%	-	-10.12%
Return on Equity (ROE)	69.42%	36.72%	101.77%	61.69%	19.87%	12.08%	10.03%	-6.13%	0.57%	-	-20.56%
Cash Return on Invested Capital (CROIC)	-4.85%	7.85%	-156.85%	8.72%	-0.54%	18.27%	2.16%	-2.02%	-0.27%	-	1.49%
Operating Return on Assets (OROA)	11.91%	9.53%	15.82%	16.66%	6.54%	6.46%	4.73%	-1.58%	0.34%	-	-6.46%
Return on Assets (ROA)	7.31%	5.02%	9.66%	11.01%	3.54%	2.10%	1.91%	-2.64%	-0.32%	-	-6.94%
Return on Common Equity (ROCE)	63.69%	34.54%	97.69%	59.18%	19.40%	11.60%	9.65%	-5.92%	0.56%	-	-19.72%
Return on Equity Simple (ROE_SIMPLE)	34.43%	0.00%	37.05%	38.18%	30.04%	0.00%	19.82%	0.00%	0.00%	-	0.00%
Net Operating Profit after Tax (NOPAT)	41	30	56	68	21	14	11	-5.95	1.61	-26	-20
NOPAT Margin	4.05%	2.92%	5.34%	5.81%	2.06%	1.35%	1.21%	-0.62%	0.16%	-	-2.46%
Net Nonoperating Expense Percent (NNEP)	1.03%	1.05%	2.53%	0.96%	0.85%	1.12%	0.64%	1.99%	0.95%	-	2.87%
Return On Investment Capital (ROIC_SIMPLE)	-	2.66%	-	-	-	1.57%	1.10%	-0.58%	0.16%	-2.68%	-2.09%
Cost of Revenue to Revenue	79.66%	79.59%	77.69%	77.80%	81.02%	80.55%	80.48%	82.42%	84.08%	-	84.31%
SG&A Expenses to Revenue	14.48%	15.67%	14.38%	14.01%	15.73%	14.30%	17.16%	16.83%	15.59%	-	19.01%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Operating Expenses to Revenue	14.48%	15.67%	14.38%	14.01%	15.73%	14.94%	17.10%	18.47%	15.79%	-	20.59%
Earnings before Interest and Taxes (EBIT)	59	49	85	97	33	33	22	-8.00	1.80	-38	-28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	71	61	97	109	45	45	33	4.20	13	-26	-17
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.46	2.68	2.66	2.62	2.11	1.88	1.44	1.29	1.22	-	1.35
Price to Tangible Book Value (P/TBV)	3.50	3.52	3.40	3.23	2.56	2.30	1.73	1.55	1.46	-	1.69
Price to Revenue (P/Rev)	0.19	0.25	0.26	0.29	0.26	0.21	0.18	0.18	0.17	-	0.16
Price to Earnings (P/E)	7.29	8.30	7.28	6.94	7.10	6.27	7.40	31.73	241.92	-	0.00
Dividend Yield	2.97%	2.13%	2.04%	1.90%	2.12%	2.70%	3.37%	3.54%	3.85%	-	4.43%
Earnings Yield	13.72%	12.04%	13.74%	14.41%	14.09%	15.96%	13.52%	3.15%	0.41%	-	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.61	2.15	1.85	1.86	1.64	1.52	1.24	1.16	1.13	-	1.17
Enterprise Value to Revenue (EV/Rev)	0.29	0.40	0.35	0.38	0.34	0.28	0.27	0.27	0.26	-	0.27
Enterprise Value to EBITDA (EV/EBITDA)	5.03	6.52	4.98	4.79	4.66	4.05	4.77	8.43	10.59	-	0.00
Enterprise Value to EBIT (EV/EBIT)	6.29	7.97	5.92	5.59	5.52	4.85	6.03	13.52	20.97	-	0.00
Enterprise Value to NOPAT (EV/NOPAT)	9.41	11.25	8.58	8.30	8.27	7.44	9.57	32.13	114.28	-	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	10.26	11.03	8.99	12.87	10.72	7.03	9.91	7.49	9.18	-	10.88
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	29.15	0.00	22.95	0.00	8.41	60.66	0.00	0.00	-	76.01
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.59	1.81	1.11	1.04	0.88	0.89	0.91	0.84	0.84	-	1.12
Long-Term Debt to Equity	0.76	1.19	0.56	0.52	0.46	0.49	0.46	0.44	0.45	-	0.56
Financial Leverage	1.77	1.30	0.86	1.05	0.87	0.73	0.76	0.72	0.64	-	0.76
Leverage Ratio	8.74	6.50	4.93	5.36	4.94	4.56	4.35	4.01	3.89	-	4.09
Compound Leverage Factor	7.76	5.55	4.47	4.99	4.22	3.33	3.39	6.61	-9.93	-	4.66
Debt to Total Capital	61.43%	64.38%	52.52%	51.01%	46.73%	47.14%	47.76%	45.65%	45.72%	-	52.84%
Short-Term Debt to Total Capital	32.17%	22.13%	26.00%	25.75%	22.05%	21.27%	23.82%	22.00%	21.07%	-	26.58%
Long-Term Debt to Total Capital	29.26%	42.26%	26.51%	25.25%	24.68%	25.88%	23.94%	23.65%	24.65%	-	26.26%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	0.00%
Noncontrolling Interests to Total Capital	1.95%	1.48%	1.90%	1.67%	0.41%	2.03%	1.91%	1.80%	1.90%	-	2.18%
Common Equity to Total Capital	36.62%	34.14%	45.58%	47.33%	52.86%	50.82%	50.33%	52.55%	52.38%	-	44.98%
Debt to EBITDA	2.25	2.88	1.60	1.49	1.50	1.49	2.08	3.72	4.89	-	-20.62
Net Debt to EBITDA	1.66	2.35	1.22	1.13	1.07	0.97	1.53	2.75	3.56	-	-15.17
Long-Term Debt to EBITDA	1.07	1.89	0.81	0.74	0.79	0.82	1.04	1.93	2.64	-	-10.25
Debt to NOPAT	4.20	4.98	2.76	2.57	2.67	2.73	4.17	14.16	52.79	-	-10.11
Net Debt to NOPAT	3.11	4.06	2.10	1.96	1.90	1.79	3.06	10.49	38.38	-	-7.44
Long-Term Debt to NOPAT	2.00	3.27	1.39	1.27	1.41	1.50	2.09	7.34	28.46	-	-5.02
Altman Z-Score	2.59	2.76	2.87	3.05	2.89	3.01	2.84	2.65	2.64	-	2.42
Noncontrolling Interest Sharing Ratio	8.25%	5.95%	4.01%	4.07%	2.38%	3.98%	3.82%	3.36%	2.16%	-	4.10%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.16	1.22	1.25	1.31	1.36	1.35	1.38	1.40	1.39	-	1.31
Quick Ratio	0.45	0.47	0.48	0.55	0.54	0.55	0.55	0.56	0.57	-	0.56
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-112	-61	-740	-57	-159	-4.10	-87	-57	-9.69	-46	43
Operating Cash Flow to CapEx	763.29%	288.61%	320.00%	-21.37%	715.31%	461.14%	-353.40%	227.56%	261.27%	-	-353.76%
Free Cash Flow to Firm to Interest Expense	-11.62	-6.67	-83.17	-6.45	-18.93	-0.53	-11.26	-7.27	-1.21	-	6.00
Operating Cash Flow to Interest Expense	6.28	5.01	2.52	-0.28	8.35	10.48	-4.73	3.66	4.64	-	-4.57
Operating Cash Flow Less CapEx to Interest Expense	5.46	3.27	1.73	-1.61	7.18	8.21	-6.06	2.05	2.86	-	-5.86
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.01	2.01	1.97	2.01	2.02	2.10	1.99	1.89	1.85	-	1.82
Accounts Receivable Turnover	8.25	8.07	8.02	7.33	8.09	8.74	8.11	7.24	7.36	-	7.48
Inventory Turnover	4.12	4.13	3.95	4.15	4.03	4.35	4.12	4.09	4.02	-	4.34
Fixed Asset Turnover	13.34	13.20	13.39	13.92	13.87	13.88	13.32	12.59	12.28	-	11.41
Accounts Payable Turnover	6.01	6.01	5.88	6.17	6.31	7.03	6.46	6.59	6.41	-	7.12
Days Sales Outstanding (DSO)	44.26	45.25	45.50	49.81	45.09	41.76	45.01	50.39	49.57	-	48.81
Days Inventory Outstanding (DIO)	88.61	88.45	92.32	87.89	90.47	83.96	88.63	89.27	90.88	-	84.09
Days Payable Outstanding (DPO)	60.75	60.75	62.05	59.13	57.84	51.94	56.54	55.36	56.95	-	51.29
Cash Conversion Cycle (CCC)	72.12	72.95	75.76	78.58	77.72	73.78	77.11	84.30	83.50	-	81.62
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	708	772	797	872	888	790	894	923	900	810	832
Invested Capital Turnover	6.34	5.67	10.48	5.25	5.35	5.52	4.92	4.40	4.38	-	4.23
Increase / (Decrease) in Invested Capital	152	91	797	125	180	19	98	52	11	20	-63
Enterprise Value (EV)	1,143	1,662	1,475	1,619	1,453	1,199	1,109	1,074	1,013	-	974
Market Capitalization	749	1,045	1,098	1,220	1,116	892	735	704	653	-	582
Book Value per Share	$17.72	$22.69	$23.77	$26.62	$30.28	$27.14	$28.82	$30.76	$30.25	$26.62	$24.03
Tangible Book Value per Share	$12.44	$17.30	$18.62	$21.62	$24.88	$22.13	$24.06	$25.72	$25.25	$21.65	$19.25
Total Capital	831	1,142	904	984	1,003	935	1,013	1,037	1,023	987	956
Total Debt	511	735	475	502	469	441	484	473	468	494	505
Total Long-Term Debt	243	483	240	249	247	242	243	245	252	252	251
Net Debt	378	600	361	383	333	289	355	351	340	313	372
Capital Expenditures (CapEx)	7.90	16	7.00	12	9.80	18	10	13	14	23	9.30
Debt-free, Cash-free Net Working Capital (DFCFNWC)	391	445	478	545	556	478	565	576	551	464	485
Debt-free Net Working Capital (DFNWC)	469	524	540	611	632	574	642	643	622	588	566
Net Working Capital (NWC)	202	272	305	358	411	375	401	415	407	345	312
Net Nonoperating Expense (NNE)	4.15	4.31	4.65	3.98	3.17	3.70	2.33	7.45	3.31	26	11
Net Nonoperating Obligations (NNO)	388	365	367	390	354	296	365	360	344	318	381
Total Depreciation and Amortization (D&A)	12	12	12	13	12	12	11	12	12	12	12
Debt-free, Cash-free Net Working Capital to Revenue	9.75%	10.82%	11.45%	12.81%	13.03%	11.09%	13.58%	14.57%	14.09%	-	13.26%
Debt-free Net Working Capital to Revenue	11.70%	12.73%	12.94%	14.37%	14.80%	13.33%	15.43%	16.26%	15.90%	-	15.50%
Net Working Capital to Revenue	5.03%	6.59%	7.31%	8.41%	9.62%	8.71%	9.63%	10.49%	10.39%	-	8.54%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$1.48	$2.97	$3.62	$0.98	$0.59	$0.49	($0.79)	($0.13)	($2.97)	($1.71)
Adjusted Weighted Average Basic Shares Outstanding	0.00	17.49M	17.34M	17.49M	17.50M	17.70M	17.56M	17.71M	17.72M	17.90M	17.82M
Adjusted Diluted Earnings per Share	$0.00	$1.42	$2.93	$3.58	$0.97	$0.56	$0.48	($0.79)	($0.13)	($2.96)	($1.71)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	17.49M	17.59M	17.66M	17.75M	17.70M	17.77M	17.71M	17.72M	17.90M	17.82M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	17.49M	17.50M	17.50M	17.51M	17.70M	17.71M	17.72M	17.73M	17.90M	17.92M
Normalized Net Operating Profit after Tax (NOPAT)	41	30	56	68	21	23	11	5.04	3.01	13	-11
Normalized NOPAT Margin	4.05%	2.92%	5.34%	5.81%	2.06%	2.12%	1.18%	0.53%	0.31%	-	-1.36%
Pre Tax Income Margin	5.25%	4.06%	7.28%	7.70%	2.77%	2.25%	1.85%	-1.38%	-0.47%	-	-4.04%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.18	5.36	9.53	10.99	3.92	4.27	2.81	-1.01	0.23	-	-3.92
NOPAT to Interest Expense	4.22	3.30	6.34	7.71	2.50	1.87	1.43	-0.75	0.20	-	-2.72
EBIT Less CapEx to Interest Expense	5.35	3.63	8.74	9.66	2.75	2.00	1.47	-2.62	-1.55	-	-5.21
NOPAT Less CapEx to Interest Expense	3.40	1.56	5.56	6.38	1.33	-0.40	0.09	-2.36	-1.57	-	-4.01
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	22.33%	18.42%	15.52%	13.67%	15.58%	17.55%	25.52%	109.66%	611.63%	-	-27.73%
Augmented Payout Ratio	22.33%	18.42%	15.52%	13.67%	15.58%	7.84%	7.12%	31.09%	179.07%	-	-19.18%

Financials Breakdown Chart

Key Financial Trends

Here are the key trends for Hyster-Yale (NYSE: HY) based on quarterly results across the last four years, with a focus on how cash flow, profitability, and leverage have evolved.

Q4 2025: Net cash from continuing operating activities was 56,500,000, showing positive cash generation from core operations despite a quarterly net loss.
Q4 2025: Issuance of debt totaled 72,000,000 during the quarter, providing additional liquidity to support financing needs.
Q4 2025: Net cash from financing activities was 26,600,000, contributing to overall quarterly cash inflows alongside debt issuance.
Q1 2025: Net income attributable to common shareholders was 8,600,000, with basic and diluted earnings per share of 0.49 and 0.48 respectively, signaling a profitable quarter before later charges.
Revenue has trended down from about 1.016 billion in Q3 2024 to 0.923 billion in Q4 2025, indicating slower top-line growth over the period.
Total current liabilities around 1.037 billion (Q3 2025) versus total current assets of about 1.444 billion yields a modest current ratio near 1.39, suggesting only a thin liquidity cushion.
Total liabilities in Q3 2025 were about 1.505 billion with total equity around 0.536 billion, implying a leverage profile above 2x (liabilities to equity) and indicating a higher financial risk level.
Q4 2025: Net income attributable to common shareholders was -52,500,000, reflecting a substantial quarterly loss.
Q4 2025: Total operating income was -37,200,000, driven by elevated operating costs and restructuring charges.
Q4 2025: Restructuring charge of 55,899,999.5 increased costs and contributed to the quarterly loss, signaling significant one-time repositioning costs.

07/14/26 09:59 AM ETAI Generated. May Contain Errors.

Hyster-Yale Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Hyster-Yale's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Hyster-Yale's net income appears to be on a downward trend, with a most recent value of -$58 million in 2025, falling from $75.10 million in 2015. The previous period was $144.20 million in 2024. Check out Hyster-Yale's forecast to explore projected trends and price targets.

Hyster-Yale's total operating income in 2025 was -$22.10 million, based on the following breakdown:

Total Gross Profit: $632.80 million
Total Operating Expenses: $696.40 million

Over the last 10 years, Hyster-Yale's total revenue changed from $2.58 billion in 2015 to $3.77 billion in 2025, a change of 46.2%.

Hyster-Yale's total liabilities were at $1.53 billion at the end of 2025, a 0.4% decrease from 2024, and a 141.3% increase since 2015.

In the past 10 years, Hyster-Yale's cash and equivalents has ranged from $0.00 in 2021 to $220.10 million in 2017, and is currently $123.20 million as of their latest financial filing in 2025.

Over the last 10 years, Hyster-Yale's book value per share changed from 28.22 in 2015 to 26.62 in 2025, a change of -5.7%.

Related Companies

Financial statements for NYSE:HY last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hyster-Yale (HY) Financials

Financials Breakdown Chart

Key Financial Trends

Hyster-Yale Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hyster-Yale (HY) Financials

Annual Income Statements for Hyster-Yale

Quarterly Income Statements for Hyster-Yale

Annual Cash Flow Statements for Hyster-Yale

Quarterly Cash Flow Statements for Hyster-Yale

Annual Balance Sheets for Hyster-Yale

Quarterly Balance Sheets for Hyster-Yale

Annual Metrics And Ratios for Hyster-Yale

Quarterly Metrics And Ratios for Hyster-Yale

Financials Breakdown Chart

Key Financial Trends

Hyster-Yale Financials - Frequently Asked Questions

When does Hyster-Yale's financial year end?

How has Hyster-Yale's net income changed over the last 10 years?

What is Hyster-Yale's operating income?

How has Hyster-Yale's revenue changed over the last 10 years?

How much debt does Hyster-Yale have?

How much cash does Hyster-Yale have?

How has Hyster-Yale's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools